US Stock MarketDetailed Quotes

Camp4 Therapeutics (CAMP)

Watchlist
  • 4.440
  • 0.0000.00%
Close Apr 24 16:00 ET
  • 4.440
  • 0.0000.00%
Post 20:01 ET
230.55MMarket Cap-1.68P/E (TTM)

Camp4 Therapeutics (CAMP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
436.50%3.5M
-46.63%348K
795K
1.5M
858K
86.29%652K
652K
0
0
0
Operating revenue
436.50%3.5M
-46.63%348K
--795K
--1.5M
--858K
86.29%652K
--652K
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
3.38%55.56M
-10.64%13.12M
3.23%13.95M
14.71%14.53M
8.41%13.96M
2.89%53.74M
8.98%14.69M
6.53%13.52M
12.66M
12.88M
Selling and administrative expenses
16.31%17.36M
1.64%4.77M
20.50%4.6M
27.77%4.18M
21.59%3.81M
28.50%14.92M
66.61%4.69M
32.94%3.81M
--3.27M
--3.14M
-General and administrative expense
16.31%17.36M
1.64%4.77M
20.50%4.6M
27.77%4.18M
21.59%3.81M
28.50%14.92M
66.61%4.69M
32.94%3.81M
--3.27M
--3.14M
Research and development costs
-1.58%38.2M
-16.40%8.36M
-3.57%9.36M
10.16%10.34M
4.17%10.15M
-4.43%38.82M
-6.24%10M
-1.19%9.7M
--9.39M
--9.74M
Operating profit
1.93%-52.06M
8.96%-12.78M
2.66%-13.16M
-2.89%-13.03M
-1.75%-13.1M
-2.33%-53.09M
-4.14%-14.03M
-9.55%-13.52M
-12.66M
-12.88M
Net non-operating interest income expense
63.46%2.17M
16.39%710K
350.00%423K
96.10%453K
48.86%588K
-52.64%1.33M
7.21%610K
-86.36%94K
231K
395K
Non-operating interest income
63.46%2.17M
16.39%710K
350.00%423K
96.10%453K
48.86%588K
-52.64%1.33M
7.21%610K
-86.36%94K
--231K
--395K
Other net income (expense)
-92,372.73%-30.52M
-19,560.69%-28.22M
-3,714.52%-2.37M
91.72%-12K
182.14%79K
85.00%-33K
274.70%145K
-31.91%-62K
-145K
28K
Gain on sale of security
---29.83M
---28.03M
---1.8M
----
----
----
----
----
----
----
Special income (charges)
---494K
--0
---494K
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--494K
--0
--494K
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-481.82%-192K
-229.66%-188K
-14.52%-71K
91.72%-12K
182.14%79K
85.00%-33K
274.70%145K
-31.91%-62K
---145K
--28K
Income before tax
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
Income tax
Net income
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
Net income continuous Operations
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
---12.58M
---12.45M
Minority interest income
Net income attributable to the parent company
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.29%-13.48M
-12.58M
-12.45M
Basic earnings per share
76.00%-2.65
-17.84%-0.7761
20.44%-0.55
3.84%-0.62
39.63%-0.62
-171.57%-11.04
38.52%-0.6586
28.34%-0.6913
-0.6448
-1.027
Diluted earnings per share
76.00%-2.65
-17.84%-0.7761
20.44%-0.55
3.84%-0.62
39.63%-0.62
-171.57%-11.04
38.52%-0.6586
28.34%-0.6913
-0.6448
-1.027
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 436.50%3.5M-46.63%348K795K1.5M858K86.29%652K652K000
Operating revenue 436.50%3.5M-46.63%348K--795K--1.5M--858K86.29%652K--652K--0--0--0
Cost of revenue
Gross profit
Operating expense 3.38%55.56M-10.64%13.12M3.23%13.95M14.71%14.53M8.41%13.96M2.89%53.74M8.98%14.69M6.53%13.52M12.66M12.88M
Selling and administrative expenses 16.31%17.36M1.64%4.77M20.50%4.6M27.77%4.18M21.59%3.81M28.50%14.92M66.61%4.69M32.94%3.81M--3.27M--3.14M
-General and administrative expense 16.31%17.36M1.64%4.77M20.50%4.6M27.77%4.18M21.59%3.81M28.50%14.92M66.61%4.69M32.94%3.81M--3.27M--3.14M
Research and development costs -1.58%38.2M-16.40%8.36M-3.57%9.36M10.16%10.34M4.17%10.15M-4.43%38.82M-6.24%10M-1.19%9.7M--9.39M--9.74M
Operating profit 1.93%-52.06M8.96%-12.78M2.66%-13.16M-2.89%-13.03M-1.75%-13.1M-2.33%-53.09M-4.14%-14.03M-9.55%-13.52M-12.66M-12.88M
Net non-operating interest income expense 63.46%2.17M16.39%710K350.00%423K96.10%453K48.86%588K-52.64%1.33M7.21%610K-86.36%94K231K395K
Non-operating interest income 63.46%2.17M16.39%710K350.00%423K96.10%453K48.86%588K-52.64%1.33M7.21%610K-86.36%94K--231K--395K
Other net income (expense) -92,372.73%-30.52M-19,560.69%-28.22M-3,714.52%-2.37M91.72%-12K182.14%79K85.00%-33K274.70%145K-31.91%-62K-145K28K
Gain on sale of security ---29.83M---28.03M---1.8M----------------------------
Special income (charges) ---494K--0---494K----------0--0--0--------
-Less:Impairment of capital assets --494K--0--494K----------0--0--0--------
Other non- operating income (expenses) -481.82%-192K-229.66%-188K-14.52%-71K91.72%-12K182.14%79K85.00%-33K274.70%145K-31.91%-62K---145K--28K
Income before tax -55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M
Income tax
Net income -55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M
Net income continuous Operations -55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M---12.58M---12.45M
Minority interest income
Net income attributable to the parent company -55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.29%-13.48M-12.58M-12.45M
Basic earnings per share 76.00%-2.65-17.84%-0.776120.44%-0.553.84%-0.6239.63%-0.62-171.57%-11.0438.52%-0.658628.34%-0.6913-0.6448-1.027
Diluted earnings per share 76.00%-2.65-17.84%-0.776120.44%-0.553.84%-0.6239.63%-0.62-171.57%-11.0438.52%-0.658628.34%-0.6913-0.6448-1.027
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More